04-Dec-2013 - Ideal Cures has launched a new mobile phone ‘app’ designed to help customers make better use of its range of coating products.
News in brief
News in brief
03-Dec-2013 - Ingredient supplier ChemCon GmbH has been cleared to make semi-solid dosage forms by German regulators.
02-Dec-2013 - BASF has raises the price of 1,4 Butanediol (BDO) and its derivatives, citing energy costs as a key factor.
27-Nov-2013 - Actavis says it is restructuring a Californian manufacturing facility at a cost of 56 jobs weeks after the announced closure of a plant in North Carolina.
25-Nov-2013 - A £25m (€40.5m) investment at an API facility in Scotland will allow GSK closer control over its manufacturing network efficiency, the firm says.
19-Nov-2013 - Royal DSM wants to merge its pharmaceutical products business with Patheon and has signed a deal with the latter's owner, investment group JLL Partners.
18-Nov-2013 - GSK has announced plans for a new manufacturing plant to "bring more medicines to the people of India" weeks after revealing that some drug wholesalers in the country have stopped buying its products.
12-Nov-2013 - Concerns new import laws would cause EU-wide API shortages now appear unfounded, but industry groups say the buffering effects of stockpiling mean it is too early to be sure.
Ingredients: Featured news
John Giannone - incoming IPEC-Americas chairman
Irwin Silverstein, COO and VP of the International Pharmaceutical Excipients...
in-Pharmatechnologist.com presents a roundup of news in the fine chemicals sector, beginning with Johnson Matthey which has started a review of its active pharmaceutical ingredient (API) business after competition in the UK impacted its third quarter margins.